Tag: Paragraph IV certification

FDA 180-Day Exclusivity Guide for Generic Drug Applicants

Barbara Lalicki April 7, 2026 Pharmacy 11 Comments

Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.

MedWatch System Explained: How FDA Tracks Drug and Device Safety

Feb, 1 2026
Bioequivalence for Inhalers, Patches, and Injections: How Generic Drugs Meet the Same Standards

Dec, 15 2025
Nasal Antihistamine Sprays: Benefits and Side Effects Explained

Oct, 27 2025
Macrolides and QT-Prolonging Drugs: Understanding Arrhythmia Risks

Apr, 9 2026
Oxcarbazepine and Bone Health: What the Evidence Shows

Sep, 21 2025

Tag: Paragraph IV certification

FDA 180-Day Exclusivity Guide for Generic Drug Applicants

Recent Post

MedWatch System Explained: How FDA Tracks Drug and Device Safety

Bioequivalence for Inhalers, Patches, and Injections: How Generic Drugs Meet the Same Standards

Nasal Antihistamine Sprays: Benefits and Side Effects Explained

Macrolides and QT-Prolonging Drugs: Understanding Arrhythmia Risks

Oxcarbazepine and Bone Health: What the Evidence Shows

Categories

Tags

Categories

Menu